The Role of Radical Prostatectomy and Lymph Node Dissection in Clinically Node Positive Patients

Giovanni Motterle, Mohamed E. Ahmed, Jack R. Andrews, R. Jeffrey Karnes

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Patients diagnosed with clinically node-positive prostate cancer represent a population that has historically been thought to harbor systemic disease. Increasing evidence supports the role of local therapies in advanced disease, but few studies have focused on this particular population. In this review we discuss the limited role for conventional cross sectional imaging for accurate nodal staging and how molecular imaging, although early results are promising, is still far from widespread clinical utilization. To date, evidence regarding the role of radical prostatectomy and pelvic lymph node dissection in clinically node-positive disease comes from retrospective studies; overall surgery appears to be a reasonable option in selected patients, with improved oncological outcomes that could be attributed to both to its potential curative role in disease localized to the pelvis and to the improved staging to help guide subsequent multimodal treatment. The role of surgery in clinically node-positive disease needs higher-level evidence but meanwhile, radical prostatectomy with extended pelvic lymph-node dissection can be offered as a part of a multimodality approach with the patient.

Original languageEnglish (US)
Article number1395
JournalFrontiers in Oncology
StatePublished - Dec 10 2019


  • cN1
  • lymph node dissection
  • prostate cancer
  • radical prostatectomy
  • staging

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'The Role of Radical Prostatectomy and Lymph Node Dissection in Clinically Node Positive Patients'. Together they form a unique fingerprint.

Cite this